43 results
8-K
EX-10.2
RCEL
AVITA Medical Inc
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
documentation (including flow charts, logic diagrams, manuals, guides, specifications, training materials, charts and pseudo codes) with respect
8-K
EX-99.2
a0a 6phnee9u
12 May 23
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
4:01pm
8-K
EX-99.1
pi796g
12 May 23
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
4:01pm
8-K
EX-99.1
i9bl1 3pn
1 Mar 22
Results of Operations and Financial Condition
12:43pm
10-KT
eym v2eou67
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.10
1nvaz 6wuqapu
28 Feb 22
Annual report (with FYE transition)
4:11pm
8-K
EX-99.2
jz3h6d6r8g07gae8
27 Aug 21
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results
12:00am
8-K
EX-99.1
90exet po824y2
24 May 21
AVITA Medical Reports Third Quarter 2021 Financial Results
4:33pm
10-K
5nf6p
27 Aug 20
Annual report
12:00am
8-K12B
EX-14.1
9mpp1u1hjg0bcm2n
30 Jun 20
Notification of registration of securities
9:07am